What is Kyverna Therapeutics, Inc.'s capex?

Kyverna Therapeutics, Inc. (KYTX) reported capex of $2K in Q3 2025.

How has Kyverna Therapeutics, Inc.'s capex changed year-over-year?

Kyverna Therapeutics, Inc.'s capex decreased by 98.0% year-over-year, from $102K to $2K.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Kyverna Therapeutics, Inc. KYTX CapEx

CapEx at other companies

Bristol-Myers SquibbBMY

$347M+33.5%

Gilead SciencesGILD

$117M+12.5%

Climb Bio, Inc.CLYM

$109K—

Artiva Biotherapeutics, Inc.ARTV

$242K-52.6%

Iovance Biotherapeutics, Inc.IOVA

$6.61M+6.4%

Viridian Therapeutics, Inc.VRDN

$23K-73.3%

Other financials

Income statement

See full

Operating income-$41.4M+12.7%

Net income-$39.7M+11.0%

EPS (diluted)-$0.66+35.9%

Balance sheet

See full

Cash & equivalents$32.2M-43.4%

Total debt$9.2M+32.1%

Total equity$195.6M-12.7%

Total assets$257.0M-1.4%

Cash flow

See full

Operating cash flow-$41.6M+7.4%

Free cash flow-$33.5M+10.8%

Valuation

See full

Market cap$498.52M+276%

Enterprise value$475.49M+475%

Returns & leverage

See full

Return on equity-74.5%+74.4pp

Debt / equity0×0.0×

Current ratio8.1×+0.7×

Where this comes from

Reported directly by Kyverna Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed November 12, 2025, on SEC EDGAR. View the filing →

Ask your AI about Kyverna Therapeutics, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kyverna Therapeutics, Inc.'s capex?: Kyverna Therapeutics, Inc. (KYTX) reported capex of $2K in Q3 2025.
How has Kyverna Therapeutics, Inc.'s capex changed year-over-year?: Kyverna Therapeutics, Inc.'s capex decreased by 98.0% year-over-year, from $102K to $2K.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.